Global Liver Cancer Drug Market Size, Share, and COVID-19 Impact Analysis, By Type (Hepatoblastoma, Hepatocellular Carcinoma, Cholangio Carcinoma, & Other), By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy, & Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Industry: Healthcare
RELEASE DATE Mar 2024
REPORT ID SI4058
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type
      2. Market Attractiveness Analysis By Drug Class
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increase prevalence of liver cancer
    3. Restraints
      1.  Adverse effect of the therapies
    4. Opportunities
      1.  Increased investment in R&D activities by manufacturers
    5. Challenges
      1. Increasing strategic collaborations between organizations
  6. Global Liver Cancer Drug Market Analysis and Projection, By Type
    1. Segment Overview
    2. Hepatoblastoma
    3. Hepatocellular Carcinoma
    4. Cholangio Carcinoma
    5. Others
  7. Global Liver Cancer Drug Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Targeted Therapy
    3. Immunotherapy
    4. Chemotherapy
    5. Others
  8. Global Liver Cancer Drug Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Liver Cancer Drug Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Liver Cancer Drug Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Bayer AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Bristol-Myers Squibb Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Eisai Co., Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Exelixis, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Merck KGaA 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  AbbVie
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Amgen
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Thermo Fisher Scientific
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  AstraZeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Johnson & Johnson 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Sanofi SA
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Novartis AG.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Liver Cancer Drug Market, By Type, 2022-203(USD Billion)
  2. Global Hepatoblastoma, Liver Cancer Drug Market, By Region, 2022-2032(USD Billion)
  3. Global Hepatocellular Carcinoma, Liver Cancer Drug Market, By Region, 2022-2032(USD Billion)
  4. Global Cholangio Carcinoma, Liver Cancer Drug Market, By Region, 2022-2032(USD Billion)
  5. Global Others, Liver Cancer Drug Market, By Region, 2022-2032(USD Billion)
  6. Global <<Sub1_se5>>, Liver Cancer Drug Market, By Region, 2022-2032(USD Billion)
  7. Global Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  8. Global Targeted Therapy, Liver Cancer Drug Market, By Region, 2022-2032(USD Billion)
  9. Global Immunotherapy, Liver Cancer Drug Market, By Region, 2022-2032(USD Billion)
  10. Global Chemotherapy, Liver Cancer Drug Market, By Region, 2022-2032(USD Billion)
  11. Global Others, Liver Cancer Drug Market, By Region, 2022-2032(USD Billion)
  12. North America Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  13. North America Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  14. U.S.  Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  15. U.S.  Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  16. Canada Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  17. Canada Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  18. Mexico Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  19. Mexico Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  20. Europe Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  21. Europe Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  22. Germany Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  23. Germany Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  24. France Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  25. France Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  26. U.K.  Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  27. U.K.  Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  28. Italy Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  29. Italy Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  30. Spain Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  31. Spain Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  32. Asia Pacific Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  33. Asia Pacific Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  34. Japan Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  35. Japan Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)  
  36. China Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  37. China Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  38. India Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  39. India Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  40. South America Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  41. South America Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  42. Brazil Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  43. Brazil Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  44. The Middle East and Africa Liver Cancer Drug Market, By Type, 2022-2032(USD   Billion)
  45. The Middle East and Africa Liver Cancer Drug Market, By Drug Class, 2022-2032(USD   Billion)
  46. UAE Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  47. UAE Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)
  48. South Africa Liver Cancer Drug Market, By Type, 2022-2032(USD Billion)
  49. South Africa Liver Cancer Drug Market, By Drug Class, 2022-2032(USD Billion)

List of Figures 

  1. Global Liver Cancer Drug Market Segmentation
  2. Liver Cancer Drug Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Liver Cancer Drug Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Liver Cancer Drug Market
  20. Liver Cancer Drug Market Segmentation, By Type
  21. Liver Cancer Drug Market For Hepatoblastoma, By Region, 2022-2032 ($ Billion)
  22.  Liver Cancer Drug Market For Hepatocellular Carcinoma, By Region, 2022-2032 ($ Billion)
  23. Liver Cancer Drug Market For Cholangio Carcinoma, By Region, 2022-2032 ($ Billion)
  24. Liver Cancer Drug Market For Others, By Region, 2022-2032 ($ Billion)
  25. Liver Cancer Drug Market Segmentation, By Drug Class
  26.  Liver Cancer Drug Market For Targeted Therapy, By Region, 2022-2032 ($ Billion)
  27.  Liver Cancer Drug Market For Immunotherapy, By Region, 2022-2032 ($ Billion)
  28. Liver Cancer Drug Market For Chemotherapy, By Region, 2022-2032 ($ Billion)
  29. Liver Cancer Drug Market For Others, By Region, 2022-2032 ($ Billion)
  30. Bayer AG: Net Sales, 2022-2032 ($ Billion)
  31. Bayer AG: Revenue Share, By Segment, 2022 (%)
  32. Bayer AG: Revenue Share, By Region, 2022 (%)
  33. Bristol-Myers Squibb Company: Net Sales, 2022-2032 ($ Billion)
  34. Bristol-Myers Squibb Company: Revenue Share, By Segment, 2022 (%)
  35. Bristol-Myers Squibb Company: Revenue Share, By Region, 2022 (%)
  36. Eisai Co., Ltd.: Net Sales, 2022-2032 ($ Billion)
  37. Eisai Co., Ltd.: Revenue Share, By Segment, 2022 (%)
  38. Eisai Co., Ltd.: Revenue Share, By Region, 2022 (%)
  39. Exelixis, Inc.: Net Sales, 2022-2032 ($ Billion)
  40. Exelixis, Inc.: Revenue Share, By Segment, 2022 (%)
  41. Exelixis, Inc.: Revenue Share, By Region, 2022 (%)
  42. Merck KGaA: Net Sales, 2022-2032 ($ Billion)
  43. Merck KGaA: Revenue Share, By Segment, 2022 (%)
  44. Merck KGaA: Revenue Share, By Region, 2022 (%)
  45. AbbVie: Net Sales, 2022-2032 ($ Billion)
  46. AbbVie: Revenue Share, By Segment, 2022 (%)
  47. AbbVie: Revenue Share, By Region, 2022 (%)
  48. Amgen: Net Sales, 2022-2032 ($ Billion)
  49. Amgen: Revenue Share, By Segment, 2022 (%)
  50. Amgen: Revenue Share, By Region, 2022 (%)
  51. Thermo Fisher Scientific: Net Sales, 2022-2032 ($ Billion)
  52. Thermo Fisher Scientific: Revenue Share, By Segment, 2022 (%)
  53. Thermo Fisher Scientific: Revenue Share, By Region, 2022 (%)
  54. AstraZeneca.: Net Sales, 2022-2032 ($ Billion)
  55. AstraZeneca.: Revenue Share, By Segment, 2022 (%)
  56. AstraZeneca.: Revenue Share, By Region, 2022 (%)
  57. Johnson & Johnson: Net Sales, 2022-2032 ($ Billion)
  58. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  59. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  60. Sanofi SA: Net Sales, 2022-2032 ($ Billion)
  61. Sanofi SA: Revenue Share, By Segment, 2022 (%)
  62. Sanofi SA: Revenue Share, By Region, 2022 (%)
  63. Novartis AG.: Net Sales, 2022-2032 ($ Billion)
  64. Novartis AG.: Revenue Share, By Segment, 2022 (%)
  65. Novartis AG.: Revenue Share, By Region, 2022 (%)
  66. Others: Net Sales, 2022-2032 ($ Billion)
  67. Others: Revenue Share, By Segment, 2022 (%)
  68. Others: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:10.90%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies